Tissue Engineering Market Research Report - Global Forecast till 2027

Tissue Engineering Market: Information by Material (Nano-fibrous Material, Biomimetic Material, Composite Material and Nano-composite Material) by Application (Orthopedics, Musculoskeletal and Spine, Skin/Integumentary, Cancer, Dental, Cardiology, Urology, Neurology, Cord Blood & Cell Banking and GI & Gynecology) and Region - Forecast till 2027

ID: MRFR/LS/1592-CR | February 2021 | Region: Global | 116 pages

Impact of COVID-19 on the Global Tissue Engineering Market


In light of the current novel coronavirus (COVID-19) pandemic, there is a dire need for new diagnostic and therapeutic strategies to combat such diseases worldwide. Tissue engineering has traditionally focused on the application of engineering principles to biological systems, collaboration across disciplines, and rapid translation of technologies.


One of the prime challenges posed by the COVID-19 pandemic includes the availability of supplies in the tissue engineering market. Shipments of various laboratory supplies and products have been canceled and in most cases, the delivery of most of the supplies got delayed. This made research laboratories and research-driven companies difficult to choose alternative solutions, severely affecting the productivity of laboratory research in the last few months.


Financial risks include high risk of research uncertainty along with the current socio-economic pressures to reduce the cost of any novel tissue engineering products which may be used in the treatment of diseases. Other risks are currency volatility and the high fixed cost and operating costs which pushes the mid-sized enterprises at a huge risk of loss.


The technological advancements in the tissue engineering field in the past decade has revolutionized the field of plastic surgery. As compared to plastic surgery, tissue engineering has proved to be more modern and interdisciplinary. The increasing preference of society for using stem cells, PRP (platelet-rich plasma), growth factors, and synthetic scaffolds to treat facial defects are significant factors providing opportunities for the global tissue engineering market. However, in the previous quarter, most of the regulatory authorities did not permit medical professionals to carry on with cosmetic surgeries. Owing to this, there is a significant gap created in the demand and supply of tissue engineering products.


While the whole world is afraid to reach the point of economic crisis, 3D bioprinting is emerging as a novel tissue engineering strategy due to its cost-efficiency. This technology includes a precise layering of cells, growth factors, and biological scaffolds to create bioidentical tissues. 3D bioprinting has the ability to produce healthcare products at cheap costs. The cost of 3D bioprinting is becoming low for small production runs. 3D bioprinting is also capable of reducing manufacturing costs by decreasing the use of unnecessary resources. While some technology companies have been using other means to address the personal protective equipment shortage caused by COVID-19, others are using 3D printing technology to create samples of human organs and tissues for coronavirus testing. Since public health officials are racing to find treatments for COVID-19, researchers and scientists are continuously working to aid the challenges. For instance, companies such as Novoheart Holdings Inc., are trying to speed up traditional drug and vaccine development processes without compromising patient safety by creating miniaturized versions of organs using 3D bioprinting and stem cell engineering. As many companies speed up the production of therapies and vaccines, with emergency authorization approvals and regulatory guidelines, 3D organs may see greater use as researchers, and companies are seeking a quick way for the testing of the effects of drug therapies.


Several companies operating in this market are focused on improving community conditions all over the world. For instance, as on 7th May 2020, Allergan plc announced that the Allergan Foundation has fast-tracked another USD 2 million in charitable grants for community organizations responding to the COVID-19 pandemic. The new grants double the Allergan Foundation's total COVID-19 donations, raising the total to USD 4 million. The donations are dedicated to 57 organizations working on the front lines of the community response to the pandemic in the US and internationally.


The world faces a global health crisis of great magnitude. The rate of infection and mortality from COVID-19 make it unlike any virus seen in this century. Physicians and scientists are banding together to combat the threat of COVID-19. Thus, tissue engineering companies have a rare set of tools and can make substantial contributions to the development of therapeutic and diagnostic platforms.

1 Executive Summary

2 Market Introduction

2.1 Definition 14

2.2 Scope of the Study 14

2.3 Assumptions & Limitations 15

2.3.1 Assumptions 15

2.3.2 Limitations 15

2.4 Market Structure 15

3 Research Methodology

3.1 Research Process 16

3.2 Primary Research 17

3.3 Secondary Research 18

3.4 Market Size Estimation 19

3.5 Forecast Model 19

4 Market Dynamics

4.1 Overview 20

4.2 Drivers 21

4.2.1 Growing Geriatric Population 21

4.2.2 Increasing Incidence Rate of Chronic and Infectious Diseases 21

4.2.3 3D Bioprinting Emerging as a Novel Tissue Engineering Strategy due to its Cost Efficiency 21

4.2.4 Increased Focus of Companies on Tissue Engineering-Based Therapies 21

4.3 Restraints 22

4.3.1 Lack of Awareness Regarding Tissue Engineering 22

4.3.2 Lack of Skilled Professionals 22

4.3.3 Stringent Regulatory Policies 22

4.4 Opportunity 23

4.4.1 Entering Developing Economies 23

4.4.2 High Demand for Tissue Engineering in Cosmetic and Reconstructive Surgery 23

4.5 Mega Trends 23

4.6 Macroeconomic Indicators 24

6 Market Factor Analysis

5.1 Supply Chain Analysis 25

5.1.1 Raw Material 25

5.1.2 Supplier 25

5.1.3 Manufacturer 25

5.1.4 Distributor 26

5.1.5 Customer-Retailer 26

5.1.6 Consumer 26

5.2 Porter’s Five Forces Analysis 27

5.2.1 Bargaining Power of Suppliers 27

5.2.2 Bargaining Power of Buyers 28

5.2.3 Threat of New Entrants 28

5.2.4 Threat of Substitutes 28

5.2.5 Intensity of Rivalry 28

5.3 Investment Opportunities 29

5.3.1 Market Size, Growth Rate, and Profitability 29

5.3.2 Investment Risks 29

5.3.3 Market Outlook 29

5.3.4 Competitors 29

5.3.5 Projections 30

5.4 Pricing Analysis 30

5.5 Merger and Acquisition Landscape 31

7 Tissue Engineering Market, By Material

6.1 Overview 34

6.2 Nano-Fibrous Material 36

6.3 Biomimetic Material 37

6.4 Composite Material 38

6.5 Nano-Composite Material 39

8 Tissue Engineering Market, By Application

7.1 Overview 40

7.2 Orthopedics, Musculoskeletal and Spine 42

7.3 Cancer 43

7.4 Skin/Integumentary 44

7.5 Dental 45

7.6 Cardiology 46

7.7 Urology 47

7.8 Neurology 48

7.9 Cord Blood & Cell Banking 49

7.10 GI & Gynecology 50

9 Global Tissue Engineering Market, By Region

8.1 Overview 51

8.2 Americas 53

Tissue Engineering Market, By Material

Tissue Engineering Market, By Application

8.2.1 US 56

Tissue Engineering Market, By Material

Tissue Engineering Market, By Application

8.2.2 Canada 57

Tissue Engineering Market, By Material

Tissue Engineering Market, By Application

8.2.3 Latin America 59

Tissue Engineering Market, By Material

Tissue Engineering Market, By Application

8.3 Europe 61

Tissue Engineering Market, By Material

Tissue Engineering Market, By Application

8.3.1 Germany 63

Tissue Engineering Market, By Material

Tissue Engineering Market, By Application

8.3.2 France 65

Tissue Engineering Market, By Material

Tissue Engineering Market, By Application

8.3.3 UK 66

Tissue Engineering Market, By Material

Tissue Engineering Market, By Application

8.3.4 Italy 68

Tissue Engineering Market, By Material

Tissue Engineering Market, By Application

8.3.5 Spain 69

Tissue Engineering Market, By Material

Tissue Engineering Market, By Application

8.3.6 Eastern Europe 71

Tissue Engineering Market, By Material

Tissue Engineering Market, By Application

8.4 Asia-Pacific 73

Tissue Engineering Market, By Material

Tissue Engineering Market, By Application

8.4.1 Japan 76

Tissue Engineering Market, By Material

Tissue Engineering Market, By Application

8.4.2 China 77

Tissue Engineering Market, By Material

Tissue Engineering Market, By Application

8.4.3 India 78

Tissue Engineering Market, By Material

Tissue Engineering Market, By Application

8.4.4 Australia 80

Tissue Engineering Market, By Material

Tissue Engineering Market, By Application

8.4.5 Republic of Korea 81

Tissue Engineering Market, By Material

Tissue Engineering Market, By Application

8.4.6 Rest of Asia-Pacific 82

Tissue Engineering Market, By Material

Tissue Engineering Market, By Application

8.5 Middle East & Africa 84

Tissue Engineering Market, By Material

Tissue Engineering Market, By Application

8.5.1 Middle East 86

Tissue Engineering Market, By Material

Tissue Engineering Market, By Application

8.5.2 Africa 88

Tissue Engineering Market, By Material

Tissue Engineering Market, By Application

10 Competitive Landscape

9.1 Introduction 90

9.2 Company Share Analysis 90

11 Company Profiles

10.1 Stryker 92

10.1.1 Company Overview 92

10.1.2 Financial Overview 92

10.1.3 Products/Services Offered 93

10.1.4 Key Developments 93

10.1.5 SWOT Analysis 94

10.1.6 Key Strategies 94

10.2 Allergan 95

10.2.1 Company Overview 95

10.2.2 Financial Overview 95

10.2.3 Products/Services Offered 96

10.2.4 Key Developments 96

10.2.5 SWOT Analysis 96

10.2.6 Key Strategies 96

10.3 Medtronic 98

10.3.1 Company Overview 98

10.3.2 Financial Overview 98

10.3.3 Products/Services Offered 99

10.3.4 Key Developments 99

10.3.5 SWOT Analysis 99

10.3.6 Key Strategies 100

10.4 Zimmer 101

10.4.1 Company Overview 101

10.4.2 Financial Overview 101

10.4.3 Products/Services Offered 102

10.4.4 Key Developments 102

10.4.5 SWOT Analysis 102

10.4.6 Key Strategies 102

10.5 Baxter International 103

10.5.1 Company Overview 103

10.5.2 Financial Overview 103

10.5.3 Products/Services Offered 104

10.5.4 Key Developments 104

10.5.5 SWOT Analysis 104

10.5.6 Key Strategies 104

10.6 Integra LifeSciences 105

10.6.1 Company Overview 105

10.6.2 Financial Overview 105

10.6.3 Products/Services Offered 106

10.6.4 Key Developments 106

10.6.5 SWOT Analysis 106

10.6.6 Key Strategies 106

10.7 Organovo Holdings Inc. 107

10.7.1 Company Overview 107

10.7.2 Financial Overview 107

10.7.3 Products/Services Offered 108

10.7.4 Key Developments 108

10.7.5 SWOT Analysis 108

10.7.6 Key Strategies 108

10.8 Cook Medical 109

10.8.1 Company Overview 109

10.8.2 Financial Overview 109

10.8.3 Products/Services Offered 109

10.8.4 Key Developments 109

10.8.5 SWOT Analysis 110

10.8.6 Key Strategies 110

10.9 DePuy Synthes 111

10.9.1 Company Overview 111

10.9.2 Financial Overview 111

10.9.3 Products/Services Offered 112

10.9.4 Key Developments 112

10.9.5 SWOT Analysis 112

10.9.6 Key Strategies 112

10.10 Acelity 113

10.10.1 Company Overview 113

10.10.2 Financial Overview 113

10.10.3 Products Offering 113

10.10.4 Key Developments 113

10.10.5 SWOT Analysis 114

10.10.6 Key Strategies 114

12 Appendix

11.1 References 115

11.2 Related Reports 115

13 List of Tables

TABLE 1 PRIMARY INTERVIEWS 17

TABLE 2 GLOBAL TISSUE ENGINEERING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 34

TABLE 3 GLOBAL TISSUE ENGINEERING MARKET, FOR NANO-FIBROUS MATERIAL, BY REGION, 2020–2027 (USD MILLION) 36

TABLE 4 GLOBAL TISSUE ENGINEERING MARKET, FOR BIOMIMETIC MATERIAL, BY REGION, 2020–2027 (USD MILLION) 37

TABLE 5 GLOBAL TISSUE ENGINEERING MARKET, FOR COMPOSITE MATERIAL, BY REGION, 2020–2027 (USD MILLION) 38

TABLE 6 GLOBAL TISSUE ENGINEERING MARKET, FOR NANO-COMPOSITE MATERIAL, BY REGION, 2020–2027 (USD MILLION) 39

TABLE 7 GLOBAL TISSUE ENGINEERING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 40

TABLE 8 GLOBAL TISSUE ENGINEERING MARKET, FOR ORTHOPEDICS, MUSCULOSKELETAL AND SPINE, BY REGION, 2020–2027 (USD MILLION) 42

TABLE 9 GLOBAL TISSUE ENGINEERING MARKET, FOR CANCER, BY REGION, 2020–2027 (USD MILLION) 43

TABLE 10 GLOBAL TISSUE ENGINEERING MARKET, FOR SKIN/INTEGUMENTARY, BY REGION, 2020–2027 (USD MILLION) 44

TABLE 11 GLOBAL TISSUE ENGINEERING MARKET, FOR DENTAL, BY REGION, 2020–2027 (USD MILLION) 45

TABLE 12 GLOBAL TISSUE ENGINEERING MARKET, FOR CARDIOLOGY, BY REGION, 2020–2027 (USD MILLION) 46

TABLE 13 GLOBAL TISSUE ENGINEERING MARKET, FOR UROLOGY, BY REGION, 2020–2027 (USD MILLION) 47

TABLE 14 GLOBAL TISSUE ENGINEERING MARKET, FOR NEUROLOGY, BY REGION, 2020–2027 (USD MILLION) 48

TABLE 15 GLOBAL TISSUE ENGINEERING MARKET, FOR CORD BLOOD & CELL BANKING, BY REGION, 2020–2027 (USD MILLION) 49

TABLE 16 GLOBAL TISSUE ENGINEERING MARKET, FOR GI & GYNECOLOGY, BY REGION, 2020–2027 (USD MILLION) 50

TABLE 17 GLOBAL TISSUE ENGINEERING MARKET, BY REGION, 2020–2027 (USD MILLION) 51

TABLE 18 GLOBAL TISSUE ENGINEERING MARKET, BY REGION, 2020 & 2027 (USD MILLION) 52

TABLE 19 AMERICAS: TISSUE ENGINEERING MARKET, BY REGION, 2020–2027 (USD MILLION) 53

TABLE 20 AMERICAS: TISSUE ENGINEERING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 54

TABLE 21 AMERICAS: TISSUE ENGINEERING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 55

TABLE 22 US: TISSUE ENGINEERING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 56

TABLE 23 US: TISSUE ENGINEERING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 56

TABLE 24 CANADA: TISSUE ENGINEERING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 57

TABLE 25 CANADA: TISSUE ENGINEERING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 58

TABLE 26 LATIN AMERICA: TISSUE ENGINEERING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 59

TABLE 27 LATIN AMERICA: TISSUE ENGINEERING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 60

TABLE 28 EUROPE: TISSUE ENGINEERING MARKET, BY REGION, 2020–2027 (USD MILLION) 61

TABLE 29 EUROPE: TISSUE ENGINEERING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 62

TABLE 30 EUROPE: TISSUE ENGINEERING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 63

TABLE 31 GERMANY: TISSUE ENGINEERING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 63

TABLE 32 GERMANY: TISSUE ENGINEERING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 64

TABLE 33 FRANCE: TISSUE ENGINEERING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 65

TABLE 34 FRANCE: TISSUE ENGINEERING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 65

TABLE 35 UK: TISSUE ENGINEERING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 66

TABLE 36 UK: TISSUE ENGINEERING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 67

TABLE 37 ITALY: TISSUE ENGINEERING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 68

TABLE 38 ITALY: TISSUE ENGINEERING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 68

TABLE 39 SPAIN: TISSUE ENGINEERING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 69

TABLE 40 SPAIN: TISSUE ENGINEERING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 70

TABLE 41 EASTERN EUROPE: TISSUE ENGINEERING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 71

TABLE 42 EASTERN EUROPE: TISSUE ENGINEERING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 72

TABLE 43 ASIA-PACIFIC: TISSUE ENGINEERING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 73

TABLE 44 ASIA-PACIFIC: TISSUE ENGINEERING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 74

TABLE 45 ASIA-PACIFIC: TISSUE ENGINEERING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 75

TABLE 46 JAPAN: TISSUE ENGINEERING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 76

TABLE 47 JAPAN: TISSUE ENGINEERING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 76

TABLE 48 CHINA: TISSUE ENGINEERING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 77

TABLE 49 CHINA: TISSUE ENGINEERING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 78

TABLE 50 INDIA: TISSUE ENGINEERING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 78

TABLE 51 INDIA: TISSUE ENGINEERING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 79

TABLE 52 AUSTRALIA: TISSUE ENGINEERING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 80

TABLE 53 AUSTRALIA: TISSUE ENGINEERING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 80

TABLE 54 REPUBLIC OF KOREA: TISSUE ENGINEERING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 81

TABLE 55 REPUBLIC OF KOREA: TISSUE ENGINEERING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 82

TABLE 56 REST OF ASIA-PACIFIC: TISSUE ENGINEERING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 82

TABLE 57 REST OF ASIA-PACIFIC: TISSUE ENGINEERING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 83

TABLE 58 MIDDLE EAST & AFRICA: TISSUE ENGINEERING MARKET, BY REGION, 2020–2027 (USD MILLION) 84

TABLE 59 MIDDLE EAST & AFRICA: TISSUE ENGINEERING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 85

TABLE 60 MIDDLE EAST & AFRICA: TISSUE ENGINEERING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 85

TABLE 61 MIDDLE EAST: TISSUE ENGINEERING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 86

TABLE 62 MIDDLE EAST: TISSUE ENGINEERING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 87

TABLE 63 AFRICA: TISSUE ENGINEERING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 88

TABLE 64 AFRICA: TISSUE ENGINEERING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 89

14 List of Figures

FIGURE 1 MARKET SYNOPSIS 13

FIGURE 2 GLOBAL TISSUE ENGINEERING MARKET: MARKET STRUCTURE 15

FIGURE 3 RESEARCH PROCESS 16

FIGURE 4 TOP-DOWN & BOTTOM-UP APPROACH 19

FIGURE 5 MARKET DYNAMICS: GLOBAL TISSUE ENGINEERING MARKET 20

FIGURE 6 SUPPLY CHAIN: GLOBAL TISSUE ENGINEERING MARKET 25

FIGURE 7 PORTER’S FIVE FORCES ANALYSIS: GLOBAL TISSUE ENGINEERING MARKET 27

FIGURE 8 GLOBAL TISSUE ENGINEERING MARKET SHARE, BY MATERIAL, 2020 (%) 35

FIGURE 9 GLOBAL TISSUE ENGINEERING MARKET, BY MATERIAL, 2020 & 2027 (USD MILLION) 35

FIGURE 10 GLOBAL TISSUE ENGINEERING MARKET SHARE, BY APPLICATION, 2020 (%) 41

FIGURE 11 GLOBAL TISSUE ENGINEERING MARKET, BY APPLICATION, 2020 & 2027 (USD MILLION) 41

FIGURE 12 GLOBAL TISSUE ENGINEERING MARKET SHARE, BY REGION, 2020 (%) 52

FIGURE 13 AMERICAS: TISSUE ENGINEERING MARKET SHARE, BY REGION, 2020 (%) 54

FIGURE 14 EUROPE: TISSUE ENGINEERING MARKET SHARE, BY COUNTRY, 2020 (%) 62

FIGURE 15 ASIA-PACIFIC: TISSUE ENGINEERING MARKET SHARE, BY COUNTRY, 2020 (%) 74

FIGURE 16 MIDDLE EAST & AFRICA: TISSUE ENGINEERING MARKET SHARE, BY REGION, 2020 (%) 84

FIGURE 17 GLOBAL TISSUE ENGINEERING MARKET, COMPANY SHARE ANALYSIS 2020 (%) 90

FIGURE 18 GLOBAL TISSUE ENGINEERING MARKET: COMPETITIVE LANDSCAPE 2020 (%) 91